Lilly buying cancer-research firm for $64M
Eli Lilly and Co. has agreed to spend $64 million to acquire SGX Pharmaceuticals Inc., a San Diego-based biotech firm developing cancer drugs. Indianapolis-based Lilly and SGX have been collaborating since 2003 on development of cancer drugs. SGX provided X-ray crystallography technology to determine the structure of cancer targets Lilly was trying to hit with […]